Table 1.
Participant characteristics, stratified by HCV and HIV infection status
HCV/HIV Infection Status | ||||
---|---|---|---|---|
Uninfected (n=166) |
HCV-monoinfected (n=703) |
HCV/HIV-coinfected (n=322) |
p-valuea | |
Age, mean [SD] | 42.9 [7.9] | 47.6 [8.3] | 46.8 [6.4] | <0.001 |
Female sex | 40.4 | 33.7 | 36.0 | 0.26 |
African Americanb | 89.2 | 84.5 | 93.5 | <0.001 |
Married, ever | 27.1 | 40.2 | 27.2 | <0.001 |
Employedc | 31.3 | 27.3 | 20.2 | 0.012 |
Homelessc | 13.9 | 16.8 | 14.3 | 0.49 |
Cigarette usec | 83.7 | 85.8 | 81.9 | 0.27 |
Alcohol use, ≥1 day/weekc | 61.5 | 55.2 | 45.5 | 0.001 |
Injection drug use intensityc | ||||
None | 61.5 | 50.5 | 57.8 | 0.001 |
<Daily | 21.7 | 24.5 | 27.3 | |
≥Daily | 16.9 | 25.0 | 14.9 | |
Depressive symptoms | 25.9 | 21.6 | 26.5 | 0.17 |
No. of comorbiditiesd, median [IQR] | 1 [0, 1] | 1 [0, 2] | 2 [1, 3] | <0.001 |
Chronic kidney disease | 9.7 | 20.8 | 49.8 | <0.001 |
Anemia | 14.5 | 20.2 | 37.0 | <0.001 |
Diabetes | 8.4 | 8.7 | 7.1 | 0.73 |
Hypertension | 31.7 | 42.8 | 37.2 | 0.020 |
Liver fibrosis | 12.3 | 29.9 | 40.8 | <0.001 |
Obstructive lung disease | 16.6 | 15.6 | 16.5 | 0.92 |
BMI | ||||
<25 | 45.2 | 44.5 | 54.1 | 0.019 |
25–30 | 26.8 | 33.1 | 27.7 | |
≥30 | 28.0 | 22.3 | 18.2 | |
IL−6 (pg/ml), median [IQR] | 1.37 [0.90, 2.26] | 1.56 [0.98, 2.78] | 1.82 [1.21, 3.15] | 0.002 |
CRP (mg/l), median [IQR] | 2.13 [0.94, 5.57] | 1.56 [0.53, 4.82] | 1.36 [0.51, 3.88] | 0.003 |
Abbreviations: SD = standard deviation, IQR = interquartile range, HCV = hepatitis C virus, HIV = human immunodeficiency virus, BMI = body mass index
All values given as percentages unless otherwise indicated.
p-values comparing determined using Fisher’s exact tests for categorical variables and analysis of variance for continuous variables (normal distribution) or Hodges-Lehmann’s tests on equality of medians for continuous variables (non-normal distribution).
African American race is in comparison to white/other which is 81% white, 12% other, and 7% Asian, Alaskan/Native American, and white Hispanic.
In prior 6 months.
Comorbidities include a summary score of chronic kidney disease, anemia, diabetes, hypertension, liver fibrosis, and obstructive lung disease.